Stem Cell Therapy for the Treatment of Autism and Other Disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080254005A1
SERIAL NO

12098420

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are methods, compositions of matter, and cells, useful for the treatment of autism, social integrative disorders, and various cognitive abnormalities. The invention discloses, inter alia, means of inducing angiogenesis and immune modulation either in sequence or parallel in order to substantially ameliorate or reverse the progression of autism. The use of stem cells, and cells naturally possessing or endowed with angiogenic and anti-inflammatory activity are disclosed for autism either alone or in combination with various therapeutic interventions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
Medistem LabortoriesSCOTTSDALE, AZ1

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ichim, Thomas E San Diego, CA 27 197
Riordan, Neil H Chandler, AZ 35 200

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (1)
* 2001/0009,663 NON-LETHAL METHODS FOR CONDITIONING A RECIPIENT FOR BONE MARROW TRANSPLANTATION 0 1999
 
CURIS, INC. (1)
* 2003/0022,819 Angiogenesis-modulating compositions and uses 26 2001
 
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (1)
* 5958774 Method for gene transfer into cells activated from a quiescent state 3 1997
 
RELIANCE LIFE SCIENCES PYT. LTD. (1)
* 2005/0059,152 In vitro culture of mesenchymal stem cells (MSC) and a process for the preparation thereof for therapeutic use 6 2004
 
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, THE CATHOLIC UNIVERSITY OF KOREA (1)
* 2005/0118,147 Method of using mesenchymal stromal cells to increase engraftment 14 2004
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (3)
* 2010/0247,495 Treatment of Muscular Dystrophy 6 2010
* 9265755 Stem cell administration to reduce TNF-α level in CSF of an autism spectrum disorder or pervasive development disorder patient 0 2014
* 2014/0234,306 Agent and Method for Reducing Inflammatory Markers 0 2014
 
Anthrogenesis Corporation (8)
8728805 Methods and compositions for treatment of bone defects with placental cell populations 0 2009
8367409 Amnion derived adherent cells 12 2009
8562973 Treatment of sarcoidosis using placental stem cells 4 2011
8969315 Enhancement of placental stem cell potency using modulatory RNA molecules 1 2011
8591883 Placental stem cell populations 4 2012
8691217 Placental stem cell populations 1 2012
9040035 Treatment of pain using placental stem cells 1 2012
9078898 Placental stem cell populations 0 2014
 
ANTRHOGENESIS CORPORATION (1)
9198938 Amnion derived adherent cells 0 2012
 
XON Cells, Inc. (1)
* 2011/0104,100 COMPOSITIONS AND METHODS OF STEM CELL THERAPY FOR AUTISM 8 2008
* Cited By Examiner